Amit R Mehta MD

Genitourinary Oncology, Hematologic Oncology

President, Premier Hematology (Cary, NC) | Writer/Author

205 Frasier StDurham, NC 27704
Phone+1 919-351-2260
Fax+1 919-230-2311

Dr. Mehta is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mehta's full profile Already have an account?

Summary

President of Premier Hematology, an Independent Hematology & Oncology private practice combining telemedicine, university expertise, and personalized care.

Author: "The 7 Types of Doctors" on Amazon, Barnes and Noble: how insurance-driven medicine is hurting doctors, harming the healthcare of all individuals, and what we can do about it.

Education & Training

Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2007 - 2010
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2004 - 2007
Rutgers Robert Wood Johnson Medical SchoolClass of 2004
University of PennsylvaniaBSE, Bioengineering, Magna Cum Laude, 1996 - 2000

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NC State Medical License 2010 - 2027
SC State Medical License 2016 - 2027
NJ State Medical License 2007 - 2011
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification iKnowMed EHR, McKesson, 2012, 2014, 2016
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016

Clinical Trials

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
COMPLETED
PHASE3
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Start of enrollment: 2011 Jan 27
COMPLETED
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer Start of enrollment: 2011 Nov 28
COMPLETED
PHASE3

Publications & Presentations

PubMed

9 citations
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk.
Amit R Mehta, Aron Kefela, Charina Toste, Donald Sweet
Acta Haematologica. 2021-12-14
4 citations
Fostamatinib disodium hexahydrate: a novel treatment for adult immune thrombocytopenia.
Ali McBride, Pratima Nayak, Yuliya Kreychman, Leslie Todd, Anne-Marie Duliege
The American Journal of Managed Care. 2019-11-01
30 citations
Tasquinimod in the treatment of castrate-resistant prostate cancer - current status and future prospects.
Amit R. Mehta, Andrew J. Armstrong
Therapeutic Advances in Urology. 2016-02-01

Journal Articles

Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk
Amit R Mehta, Aron Kefela, Charina Toste, Donald Sweet, Acta Haematologica, 3/1/2022
Tasquinimod in the treatment of castrate-resistant prostate cancer - current status and future prospects
Amit R Mehta, Therapeutic Advances in Urology, 2/1/2016
Stomatocytosis Heralding a Case of Acute Wilsonian Crisis
Mehta AR, Salaru G, Harrison JS, Annals of Hematology, 9/24/2010

Abstracts/Posters

Differential Effects of Ferric Derisomaltose and Ferric Carboxymaltose on Fatigue in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease
Amit R. Mehta, Myles Wolf, Heinz Zoller, 2022 American Society of Hematology Annual Conference, New Orleans, LA, 12/1/2022
Phase Ib safety trial of CVX-060, an intravenous humanized monoclonal CovX body inhibiting angiopoietin 2 (Ang-2), with axitinib in patients with previously treated me...
Mehta AR et al., American Society of Clinical Oncology (ASCO), Chicago, IL, 6/2013
Stomatocytosis Heralding a Case of Acute Wilsonian Crisis: Case Report and Review of the Literature
Mehta AR, Salaru G, Harrison JS, American Society of Hematology, New Orleans, LA, 12/2009